Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Pylori
infection in Gastric carcinoma.
Introduction:
(reproduced from
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx) .
Advanced gastric cancer can be classified by its common
Type I Polypoid
Type II Fungating
B
Figure 1.2 Helicobacter pylrori. (a) Scanning electron
in tumorigenesis.
of one on the other, and will also study their relation with other
clinicopathological parameters.
1. Ang TL, Fock KM: Clinical epidemiology of gastric cancer. Singapore
medical journal 2014, 55(12):621-628.
2. Massarrat S, Stolte M: Development of gastric cancer and its
prevention. Archives of Iranian medicine 2014, 17(7):514-520.
3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM,
Forman D, Bray F: Cancer incidence and mortality worldwide: sources,
methods and major patterns in GLOBOCAN 2012. International journal
of cancer Journal international du cancer 2015, 136(5):E359-386.
4. Ohta H, Noguchi Y, Takagi K, Nishi M, Kajitani T, Kato Y: Early gastric
carcinoma with special reference to macroscopic classification.
Cancer 1987, 60(5):1099-1106.
5. Nomura AM, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ: Relation
between Helicobacter pylori cagA status and risk of peptic ulcer
disease. American journal of epidemiology 2002, 155(11):1054-1059.
6. Correa P: Human gastric carcinogenesis: a multistep and
multifactorial process--First American Cancer Society Award Lecture
on Cancer Epidemiology and Prevention. Cancer research 1992,
52(24):6735-6740.
7. Helicobacter, Cancer Collaborative G: Gastric cancer and Helicobacter
pylori: a combined analysis of 12 case control studies nested within
prospective cohorts. Gut 2001, 49(3):347-353.
8. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F:
Association between infection with Helicobacter pylori and risk of
gastric cancer: evidence from a prospective investigation. Bmj 1991,
302(6788):1302-1305.
9. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich
N, Sibley RK: Helicobacter pylori infection and the risk of gastric
carcinoma. The New England journal of medicine 1991, 325(16):1127-1131.
10. Kuipers EJ: Review article: exploring the link between Helicobacter
pylori and gastric cancer. Alimentary pharmacology & therapeutics 1999,
13 Suppl 1:3-11.
11. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M: Development
of Helicobacter pylori-induced gastric carcinoma in Mongolian
gerbils. Cancer research 1998, 58(19):4255-4259.
12. Belair C, Darfeuille F, Staedel C: Helicobacter pylori and gastric cancer:
possible role of microRNAs in this intimate relationship. Clinical
microbiology and infection : the official publication of the European Society of
Clinical Microbiology and Infectious Diseases 2009, 15(9):806-812.
13. Lauren P: The Two Histological Main Types of Gastric Carcinoma:
Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a
Histo-Clinical Classification. Acta pathologica et microbiologica
Scandinavica 1965, 64:31-49.
14. Jeong O, Park YK: Clinicopathological features and surgical treatment
of gastric cancer in South Korea: the results of 2009 nationwide
survey on surgically treated gastric cancer patients. Journal of gastric
cancer 2011, 11(2):69-77.
15. Graham DY, Alpert LC, Smith JL, Yoshimura HH: Iatrogenic Campylobacter
pylori infection is a cause of epidemic achlorhydria. The American
journal of gastroenterology 1988, 83(9):974-980.
16. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ: Attempt to fulfil Koch's
postulates for pyloric Campylobacter. The Medical journal of Australia
1985, 142(8):436-439.
17. Morris A, Nicholson G: Ingestion of Campylobacter pyloridis causes
gastritis and raised fasting gastric pH. The American journal of
gastroenterology 1987, 82(3):192-199.
18. Fox JG, Correa P, Taylor NS, Zavala D, Fontham E, Janney F, Rodriguez E,
Hunter F, Diavolitsis S: Campylobacter pylori-associated gastritis and
immune response in a population at increased risk of gastric
carcinoma. The American journal of gastroenterology 1989, 84(7):775-781.
19. Rosh JR, Kurfist LA, Benkov KJ, Toor AH, Bottone EJ, LeLeiko NS: Helicobacter
pylori and gastric lymphonodular hyperplasia in children. The
American journal of gastroenterology 1992, 87(1):135-139.
20. Genta RM, Hamner HW: The significance of lymphoid follicles in the
interpretation of gastric biopsy specimens. Archives of pathology &
laboratory medicine 1994, 118(7):740-743.
21. Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, Suovaniemi O,
Alanko A, Harkonen M: Serum levels of amidated gastrin-17 and
pepsinogen I in atrophic gastritis: an observational case-control
study. Scandinavian journal of gastroenterology 2002, 37(7):785-791.
22. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-
Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R et al: Non-
endoscopic diagnosis of atrophic gastritis with a blood test.
Correlation between gastric histology and serum levels of gastrin-17
and pepsinogen I: a multicentre study. European journal of
gastroenterology & hepatology 2003, 15(8):885-891.
23. Wei Z, Jiang X, Liu F, Qiao H, Zhou B, Zhai B, Zhang L, Zhang X, Han L, Jiang H
et al: Downregulation of Skp2 inhibits the growth and metastasis of
gastric cancer cells in vitro and in vivo. Tumour biology : the journal of
the International Society for Oncodevelopmental Biology and Medicine 2013,
34(1):181-192.
24. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG, Jr.:
Degradation of the SCF component Skp2 in cell-cycle phase G1 by
the anaphase-promoting complex. Nature 2004, 428(6979):194-198.
25. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-
mediated degradation of the CDK inhibitor p27. Nature cell biology
1999, 1(4):193-199.
26. Arbini AA, Greco M, Yao JL, Bourne P, Marra E, Hsieh JT, di Sant'agnese PA,
Moro L: Skp2 overexpression is associated with loss of BRCA2 protein
in human prostate cancer. The American journal of pathology 2011,
178(5):2367-2376.
27. Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, Huang HY, Tsai KK, Flores
LG, Shao Y et al: The Skp2-SCF E3 ligase regulates Akt ubiquitination,
glycolysis, herceptin sensitivity, and tumorigenesis. Cell 2012,
149(5):1098-1111.
28. Meng J, Ding Y, Shen A, Yan M, He F, Ji H, Zou L, Liu Y, Wang Y, Lu X et al:
Overexpression of PPARgamma can down-regulate Skp2 expression
in MDA-MB-231 breast tumor cells. Molecular and cellular biochemistry
2010, 345(1-2):171-180.
29. Huang Y, Tai AW, Tong S, Lok AS: HBV core promoter mutations promote
cellular proliferation through E2F1-mediated upregulation of S-phase
kinase-associated protein 2 transcription. Journal of hepatology 2013,
58(6):1068-1073.
30. Haque I, Banerjee S, De A, Maity G, Sarkar S, Majumdar M, Jha SS, McGragor
D, Banerjee SK: CCN5/WISP-2 promotes growth arrest of triple-
negative breast cancer cells through accumulation and trafficking of
p27 via Skp2 and FOXO3a regulation. Oncogene 2014.
31. Kitagawa M, Lee SH, McCormick F: Skp2 suppresses p53-dependent
apoptosis by inhibiting p300. Molecular cell 2008, 29(2):217-231.
32. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG,
Balk SP: Increased expression of genes converting adrenal androgens
to testosterone in androgen-independent prostate cancer. Cancer
research 2006, 66(5):2815-2825.
33. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan CH, Yang WL,
Erdjument-Bromage H, Nakayama KI, Nimer S et al: Phosphorylation-
dependent regulation of cytosolic localization and oncogenic
function of Skp2 by Akt/PKB. Nature cell biology 2009, 11(4):420-432.
34. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K, Nakayama
K, Mori M: Clinical and biological significance of S-phase kinase-
associated protein 2 (Skp2) gene expression in gastric carcinoma:
modulation of malignant phenotype by Skp2 overexpression,
possibly via p27 proteolysis. Cancer research 2002, 62(13):3819-3825.
35. Wang J, Huang Y, Guan Z, Zhang JL, Su HK, Zhang W, Yue CF, Yan M, Guan S,
Liu QQ: E3-ligase Skp2 predicts poor prognosis and maintains cancer
stem cell pool in nasopharyngeal carcinoma. Oncotarget 2014,
5(14):5591-5601.
36. Chan CH, Morrow JK, Zhang S, Lin HK: Skp2: a dream target in the
coming age of cancer therapy. Cell cycle 2014, 13(5):679-680.